Feng, X <br/><br/>
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.  [electronic resource] 

 -  Lupus  Jan 2017 
 - 62-72 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-0962 
<br/><br/><label>Standard No.: </label>10.1177/0961203316651738  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antimalarials--administration & dosage<br/>Artemisinins--administration & dosage<br/>Artesunate<br/>Blotting, Western<br/>Case-Control Studies<br/>Dose-Response Relationship, Drug<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Interferon Type I--metabolism<br/>Interferon-alpha--administration & dosage<br/>Intramolecular Oxidoreductases--drug effects<br/>Leukocytes, Mononuclear--drug effects<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Macrophage Migration-Inhibitory Factors--drug effects<br/>Male<br/>Middle Aged<br/>Phosphorylation<br/>Real-Time Polymerase Chain Reaction<br/>STAT1 Transcription Factor--genetics<br/>Time Factors<br/>Young Adult